Vaccines, Blood & Biologics
Information Request Email, September 14, 2012 - EVARREST
Tilghman, Tracy
From: Tilghman, Tracy
Sent: Friday, September 14, 2012 4:52 PM
To: 'Chung, Jessica [ETHUS]'
Cc: Shields, Mark
Subject: Reference BL# 125392/0 - Information Request
Importance: High
Dear Ms. Chung,
We are reviewing your March 30, 2012 resubmission for Fibrin Pad to be used as an adjunct to hemostasis for soft tissue bleeding during retroperitoneal, intra-abdominal, pelvic, and (non-cardiac) thoracic surgery when control of bleeding by standard surgical methods of hemostasis is ineffective or impractical. We request the following post marketing commitments from Ethicon, Inc. below:
----b(4)------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----b(4)--- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----b(4)-- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Please respond to this request as an amendment to this file, referencing the date of this request by September 19, 2012.
The review of this submission is ongoing and issues may be added, expanded upon, or modified as we continue to review this submission.
The resubmission action due date for this file is September 29, 2012. If you have any questions, please contact me at (301) 827-9427.
Sincerely,
Tracy Tilghman, MPH
Lieutenant, United States Public Health Service
Regulatory Project Manager
U.S. Food & Drug Administration
CBER/OBRR/DBA/RPMB
1401 Rockville Pike
RM 556N, HFM-380
Rockville, MD 20852
Phone: 301-827-9427
Email: tracy.tilghman@fda.hhs.gov
"THIS MESSAGE IS INTENDED ONLY FOR THE USE OF THE PARTY TO WHOM IT IS ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL, AND PROTECTED FROM DISCLOSURE UNDER LAW. If you are not the addressee, or a person authorized to deliver the document to the addressee, you are hereby notified that any review, disclosure, dissemination, copying, or other action based on the content of this communication is not authorized. If you have received this document in
error, please immediately notify the sender immediately by e-mail or phone."







